Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03476863Not ApplicableCompleted

Gastroplasty and Electrical Impedance Tomography

Role: lead

NCT02869178Unknown

Strain X Cardiopulmonary Test

Role: lead

NCT02501655Not ApplicableUnknown

Analysis of Deposition With Nebulizers Membrane

Role: lead

NCT02247856Not ApplicableCompleted

COPD AND ASSESSMENT OF RADIOLABELED AEROSOL DURING NONINVASIVE VENTILATION

Role: lead

NCT01953185Not ApplicableCompleted

MANUAL DIAPHRAGM RELEASE TECHNIQUE INCREASES TIDAL VOLUME IN ELDERLY

Role: lead

All 5 trials loaded